Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling
Fetal growth restriction (FGR) is a major cause of poor perinatal outcomes. Although several studies have been conducted to improve the prognosis of FGR in infants, no effective intrauterine treatment method has been established. This study aimed to use tadalafil, a phosphodiesterase 5 inhibitor (PD...
Main Authors: | Kayo Tanaka, Hiroaki Tanaka, Ryota Tachibana, Kento Yoshikawa, Takuya Kawamura, Sho Takakura, Hiroki Takeuchi, Tomoaki Ikeda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1474 |
Similar Items
-
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
by: Kyoka Tsuchiya, et al.
Published: (2020-12-01) -
Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
by: Hiroaki Tanaka, et al.
Published: (2019-10-01) -
Down-regulation of autophagy proteins is associated with higher mTOR expression in the placenta of pregnant women with preeclampsia
by: I.C. Weel, et al.
Published: (2023-01-01) -
Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
by: Shintaro Maki, et al.
Published: (2020-05-01) -
The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity
by: Farshid Keshavarzi, et al.
Published: (2017-10-01)